Table 5.
Azithromycin Prophylaxis Received | |||||||
---|---|---|---|---|---|---|---|
Household Member Age Category | Household Members No. | Cough Illness Type Occurring Among Household Members | Yes | No | |||
No. | Attack Rate (%) | No. | Attack Rate (%) | P Valuea | |||
All ages | 478 | 131 | 347 | ||||
Coprimaryb | 1/131 (1) | 39/347 (11) | <.001 | ||||
Secondaryc | 0/130 (0) | 36/308 (12) | <.001 | ||||
Aged >10 y | 317 | 90 | 227 | ||||
Coprimaryb | 1/90 (1) | 8/227 (4) | .45 | ||||
Secondaryc | 0/89 (0) | 14/219 (6) | .013 | ||||
Aged 1–10 y | 149 | 36 | 113 | ||||
Coprimaryb | 0/36 (0) | 29/113 (26) | <.001 | ||||
Secondaryc | 0/36 (0) | 20/84 (24) | <.001 | ||||
Aged <1 y | 12 | 5 | 7 | ||||
Coprimaryb | 0/5 (0) | 2/7 (29) | .470 | ||||
Secondaryc | 0/5 (0) | 2/5 (40) | .444 |
The primary patient in each household was excluded from these analyses.
P-value of Fisher exact test for difference in attack rate by receipt of azithromycin prophylaxis.
Coprimary illness is defined as cough onset 0–6 days after cough onset in the household primary patient.
Secondary illness is defined as cough onset 7–16 days after cough onset in the household primary patient. Attack rate calculations exclude from the denominator all persons with coprimary illnesses because persons with coprimary illnesses were not at risk for having a secondary illness.